These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 101682)

  • 21. Experimental epsilon-aminocaproic acid (EACA) administration in the presence of subarachnoid blood.
    Ewald T; Mahaley S; Goodrich J; Wilkinson R; Silver D
    J Neurosurg; 1971 Dec; 35(6):657-63. PubMed ID: 5171110
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Epsilon-aminocaproic acid in haematuria.
    Purtilo DT; Constantian HM; DeGirolami E
    Lancet; 1975 Mar; 1(7909):755. PubMed ID: 47525
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation.
    Nilsson L; Rybo G
    Acta Obstet Gynecol Scand; 1965; 44(3):467-73. PubMed ID: 5324474
    [No Abstract]   [Full Text] [Related]  

  • 24. High obstruction of urine flow as a complication of the treatment with fibrinolysis inhibitors of haematuria in haemophiliacs.
    van Itterbeek H; Vermylen J; Verstraete M
    Acta Haematol; 1968 Apr; 39(4):237-42. PubMed ID: 4969152
    [No Abstract]   [Full Text] [Related]  

  • 25. Coronary artery disease as a contraindication to the administration of aminocaproic acid. Case report.
    Jennings T; Safran M
    Arch Ophthalmol; 1987 Jul; 105(7):895. PubMed ID: 3606447
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of hematuria in a hemophiliac by epsilon aminocaproic acid with concomitant urokinase determination.
    Cohen I; Djaldetti M; Gorschein D; de Vries A
    Bibl Haematol; 1966; 26():114. PubMed ID: 5955528
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of epsilon aminocaproic acid as an adjunct to replacement therapy in hemophiliacs undergoing tooth extraction (part II).
    Evans BE
    N Y J Dent; 1981 Apr; 51(4):117-27. PubMed ID: 6784050
    [No Abstract]   [Full Text] [Related]  

  • 28. The therapeutic effect of epsilon-aminocaproic acid with special reference to atopic dermatitis.
    Reiss F
    Br J Dermatol; 1971 Jul; 85(1):76-80. PubMed ID: 4254151
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinolysis in haemophilia: the effect of epsilon-amino-caproic acid.
    Mainwaring D; Keidan SE
    Br J Haematol; 1965 Nov; 11(6):682-8. PubMed ID: 5323143
    [No Abstract]   [Full Text] [Related]  

  • 30. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases.
    MacKay AR; Sang U H; Weinstein PR
    J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical hemostasis in a hemophiliac using blockade of the inhibitor system.
    MacPherson BH; Drayton NE; Reid WO
    Am Surg; 1974 Apr; 40(4):224-8. PubMed ID: 4815881
    [No Abstract]   [Full Text] [Related]  

  • 32. [S-aminocaproic acid and hindrance to ejaculation].
    Martínez Sánchez G; Pedros C
    Aten Primaria; 1998 Jun; 22(1):63-4. PubMed ID: 9741164
    [No Abstract]   [Full Text] [Related]  

  • 33. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L
    ASDC J Dent Child; 1979; 46(1):54-6. PubMed ID: 283081
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

  • 35. Antihemophilic factor-nineteen months' experence in its production and use.
    Oka WT; Glueck HI; Mauer AM; Hoxworth PI
    Am J Med Technol; 1968 Jul; 34(7):373-87. PubMed ID: 5672102
    [No Abstract]   [Full Text] [Related]  

  • 36. Danazol in Indian haemophiliacs.
    Sundar S; Moorleedhur-Singh GS; Dube B; Singh VP; Kumar K
    J Assoc Physicians India; 1993 Jan; 41(1):23-5. PubMed ID: 8340322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthopaedic surgery in bleeders.
    Ahlberg A
    Bibl Haematol; 1970; 34():170-6. PubMed ID: 5436345
    [No Abstract]   [Full Text] [Related]  

  • 38. An in vivo assessment of factor VIII concentrates.
    Rock G; Tittley P; Fuller V
    JAMA; 1985 Aug; 254(6):777-80. PubMed ID: 3925170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M; Wegner H; Cron D
    Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
    [No Abstract]   [Full Text] [Related]  

  • 40. [On treatment trials of hemophiliacs with epsilon-aminocaproic acid (Epsamon)].
    Fonio A
    Schweiz Med Wochenschr; 1966 Dec; 96(51):1723-6. PubMed ID: 5973382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.